Heterogeneous dynamics of the fuzzy coat of full-length phospho-mimetic tau fibrils
10.1021/jacs.5c18540 · doi-reference
Biofluid biomarkers in Alzheimer’s disease and other neurodegenerative dementias
10.1038/s41586-025-10018-w · doi-reference
“Prion-like” seeding and propagation of oligomeric protein assemblies in neurodegenerative disorders
10.3389/fnins.2024.1436262 · doi-reference
Artificial intelligence-based HDX (AI-HDX) prediction reveals fundamental characteristics to protein dynamics: mechanisms on SARS-CoV-2 immune escape
10.1016/j.isci.2023.106282 · doi-reference
Insights into the consequences of co-polymerisation in the early stages of IAPP and Aβ peptide assembly from mass spectrometry
10.1039/c5an00865d · doi-reference
Tuning the rate of aggregation of hIAPP into amyloid using small-molecule modulators of assembly
10.1038/s41467-022-28660-7 · doi-reference
Surface-sampling mass spectrometry to study proteins and protein complexes
10.1042/ebc20220191 · doi-reference
Kinetics of amyloid oligomer formation
10.1146/annurev-biophys-080124-122953 · doi-reference
Recommendations and considerations for hydroxyl radical protein footprinting-mass spectrometry
10.1038/s41592-026-03083-0 · doi-reference
Oligomerization propensity governs self-assembly morphology: insights from steady-state oligomer analysis
10.1021/acs.analchem.5c02258 · doi-reference
C-Terminal radical oxidation inhibits α-Synuclein aggregation and cytotoxicity via an oxidative oligomer-disrupting pathway
10.1021/jacs.5c06792 · doi-reference
Using mass spectrometry-based methods to understand amyloid formation and inhibition of alpha-synuclein and amyloid beta
10.1002/mas.21814 · doi-reference
Analysis of amyloid beta oligomers by cyclic ion mobility-mass spectrometry
10.1007/s00216-026-06349-w · doi-reference
Collision-induced unfolding, tandem MS, Bottom-up proteomics, and interactomics for identification of protein complexes in native surface mass spectrometry
10.1021/jasms.3c00261 · doi-reference
Protein analysis by desorption electrospray ionization mass spectrometry
10.1002/mas.21900 · doi-reference
The roles of intrinsically disordered proteins in neurodegeneration
10.1016/j.bbagen.2025.130772 · doi-reference
Direct observation of “elongated” conformational states in α-Synuclein upon liquid-liquid phase separation
10.1002/anie.202205726 · doi-reference
What’s the defect? Using mass defects to study oligomerization of membrane proteins and peptides in nanodiscs with native mass spectrometry
10.1016/j.ymeth.2023.07.004 · doi-reference
Emerging biophysical origins and pathogenic implications of amyloid oligomers
10.1038/s41467-025-58335-y · doi-reference
Aβ43 levels determine the onset of pathological amyloid deposition
10.1016/j.jbc.2023.104868 · doi-reference
Submicrometer emitter ESI tips for native mass spectrometry of membrane proteins in ionic and nonionic detergents
10.1007/s13361-017-1793-x · doi-reference
Mechanism of inhibition of acid-mediated transthyretin aggregation by designed peptides
10.1016/j.jbc.2025.110594 · doi-reference
Quantitative structural proteomics in living cells by covalent protein painting
10.1016/bs.mie.2022.08.046 · doi-reference
Factors responsible for alpha-Synuclein aggregation
10.1016/bs.pmbts.2024.11.004 · doi-reference
Amyloid-β, tau protein, α-Synuclein, TDP-43, and FUS in mixed pathology: and intrinsic disorder to rule them all
10.3390/ijms27083669 · doi-reference
Structure-function relationship of alpha-synuclein fibrillar polymorphs derived from distinct synucleinopathies
10.1038/s44320-026-00199-5 · doi-reference
Alpha-synuclein interacts with regulators of ATP homeostasis in mitochondria
10.1038/s41467-025-62895-4 · doi-reference
High-resolution structural information of membrane-bound α-synuclein provides insight into the MoA of the anti-parkinson drug UCB0599
10.1073/pnas.2201910120 · doi-reference
The expanding amyloid family: structure, stability, function, and pathogenesis
10.1016/j.cell.2021.08.013 · doi-reference
A targetable N-Terminal motif orchestrates α-Synuclein oligomer-to-fibril conversion
10.1021/jacs.4c02262 · doi-reference
Interspecies variation affects islet amyloid polypeptide membrane binding
10.1021/jasms.3c00005 · doi-reference
A distinct tau oligomer strain defines the molecular and proteomic landscape of rapidly progressive Alzheimer’s disease
10.1007/s00401-026-02998-4 · doi-reference
Advances in mass spectrometry to unravel the structure and function of protein condensates
10.1038/s41596-023-00900-0 · doi-reference
Analysis of baboon IAPP provides insight into amyloidogenicity and cytotoxicity of human IAPP
10.1016/j.bpj.2019.12.027 · doi-reference
A model study to assess fibrillation and product stability to support peptide drug design
10.1021/acs.molpharmaceut.3c00996 · doi-reference
Fibrillation of human insulin B-chain by pulsed hydrogen-deuterium exchange mass spectrometry
10.1016/j.bpj.2022.10.042 · doi-reference
Dissecting the structural heterogeneity of proteins by native mass spectrometry
10.1002/pro.4612 · doi-reference
Unfolding sequence-specific enigma in monomeric α-Synuclein: implications for parkinson’s disease
10.1021/acschemneuro.5c00423 · doi-reference
Combining electron microscopy (EM) and cross-linking mass spectrometry (XL-MS) for structural characterization of protein complexes
10.1007/978-1-0716-1936-0_17 · doi-reference
Spatially constrained disulfide bond shuffling delays insulin aggregation and enhances neurotoxicity
10.1038/s41467-025-62257-0 · doi-reference
